Cite
HARVARD Citation
Yoshino, T. et al. (2019). Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE—a global phase III study. Annals of oncology. pp. 124-131. [Online].